208 related articles for article (PubMed ID: 14499865)
1. Hypertrophic agonists induce the binding of c-Fos to an AP-1 site in cardiac myocytes: implications for the expression of GLUT1.
Santalucía T; Christmann M; Yacoub MH; Brand NJ
Cardiovasc Res; 2003 Sep; 59(3):639-48. PubMed ID: 14499865
[TBL] [Abstract][Full Text] [Related]
2. A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers.
Bergman MR; Cheng S; Honbo N; Piacentini L; Karliner JS; Lovett DH
Biochem J; 2003 Feb; 369(Pt 3):485-96. PubMed ID: 12371906
[TBL] [Abstract][Full Text] [Related]
3. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
[TBL] [Abstract][Full Text] [Related]
4. Role of c-Fos/JunD in protecting stress-induced cell death.
Zhou H; Gao J; Lu ZY; Lu L; Dai W; Xu M
Cell Prolif; 2007 Jun; 40(3):431-44. PubMed ID: 17531086
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of p38 MAP kinase increases okadaic acid mediated AP-1 expression and DNA binding but has no effect on TRE dependent transcription.
Rosenberger SF; Gupta A; Bowden GT
Oncogene; 1999 Jun; 18(24):3626-32. PubMed ID: 10380884
[TBL] [Abstract][Full Text] [Related]
6. Endothelin-1-induced cardiac hypertrophy is inhibited by activation of peroxisome proliferator-activated receptor-alpha partly via blockade of c-Jun NH2-terminal kinase pathway.
Irukayama-Tomobe Y; Miyauchi T; Sakai S; Kasuya Y; Ogata T; Takanashi M; Iemitsu M; Sudo T; Goto K; Yamaguchi I
Circulation; 2004 Feb; 109(7):904-10. PubMed ID: 14967736
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
8. Regulation of glucose transporter expression in cardiac myocytes: p38 MAPK is a strong inducer of GLUT4.
Montessuit C; Rosenblatt-Velin N; Papageorgiou I; Campos L; Pellieux C; Palma T; Lerch R
Cardiovasc Res; 2004 Oct; 64(1):94-104. PubMed ID: 15364617
[TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic c-Fos induced by the YXXQ-derived STAT3 signal requires the co-operative MEK/ERK signal for its nuclear translocation.
Higashi N; Kunimoto H; Kaneko S; Sasaki T; Ishii M; Kojima H; Nakajima K
Genes Cells; 2004 Mar; 9(3):233-42. PubMed ID: 15005710
[TBL] [Abstract][Full Text] [Related]
10. E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.
Pospelova TV; Medvedev AV; Kukushkin AN; Svetlikova SB; van der Eb AJ; Dorsman JC; Pospelov VA
Gene Expr; 1999; 8(1):19-32. PubMed ID: 10543728
[TBL] [Abstract][Full Text] [Related]
11. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
12. Inverse regulation of preproendothelin-1 and endothelin-converting enzyme-1beta genes in cardiac cells by mechanical load.
Pikkarainen S; Tokola H; Kerkelä R; Ilves M; Mäkinen M; Orzechowski HD; Paul M; Vuolteenaho O; Ruskoaho H
Am J Physiol Regul Integr Comp Physiol; 2006 Jun; 290(6):R1639-45. PubMed ID: 16410403
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase is required for bryostatin 1-induced differentiation of the human acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Al-Katib AM
Cell Growth Differ; 2001 Dec; 12(12):641-7. PubMed ID: 11751459
[TBL] [Abstract][Full Text] [Related]
14. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex.
Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F
Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524
[TBL] [Abstract][Full Text] [Related]
15. Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts.
Barchowsky A; Frleta D; Vincenti MP
Cytokine; 2000 Oct; 12(10):1469-79. PubMed ID: 11023661
[TBL] [Abstract][Full Text] [Related]
16. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes.
Chen W; Bowden GT
Oncogene; 1999 Dec; 18(52):7469-76. PubMed ID: 10602506
[TBL] [Abstract][Full Text] [Related]
17. Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade.
Shoda T; Fukuda K; Uga H; Mima H; Morikawa H
Anesthesiology; 2001 Oct; 95(4):983-9. PubMed ID: 11605942
[TBL] [Abstract][Full Text] [Related]
18. PACAP and C2-ceramide generate different AP-1 complexes through a MAP-kinase-dependent pathway: involvement of c-Fos in PACAP-induced Bcl-2 expression.
Aubert N; Falluel-Morel A; Vaudry D; Xifro X; Rodriguez-Alvarez J; Fisch C; de Jouffrey S; Lebigot JF; Fournier A; Vaudry H; Gonzalez BJ
J Neurochem; 2006 Nov; 99(4):1237-50. PubMed ID: 17026529
[TBL] [Abstract][Full Text] [Related]
19. A peptide fragment of ependymin neurotrophic factor uses protein kinase C and the mitogen-activated protein kinase pathway to activate c-Jun N-terminal kinase and a functional AP-1 containing c-Jun and c-Fos proteins in mouse NB2a cells.
Adams DS; Hasson B; Boyer-Boiteau A; El-Khishin A; Shashoua VE
J Neurosci Res; 2003 May; 72(3):405-16. PubMed ID: 12692907
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of B-Raf increases c-Jun and c-Fos expression and upregulates AP-1-regulated gene transcription in insulinoma cells.
Langfermann DS; Rössler OG; Thiel G
Mol Cell Endocrinol; 2018 Sep; 472():126-139. PubMed ID: 29225069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
